Ng, L. S., Lin, Y. P., Phillippi, A., Cuevas, M., Cho, G., NG, W. L., Karpov, O., Dave, U. (2025). Risk of second primary malignancies in patients with chronic lymphocytic leukemia treated with zanubrutinib and acalabrutinib: A real-world data analysis. Blood. https://doi.org/10.1182/blood-2025-7430